ArticleClinical and experimental medicine2026
Serum TIMP-1 shows a potential association with metastatic disease in patients with pancreatic cancer: a pilot analysis without a healthy control cohort.
Ivana Vecurkovska et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.